Search research articles
Contact Us
Filters
Showing results (11-20 of 72) with videos related to
Page
of 8
Sort By:
Molecular Imaging and Biology
|
June 21, 2026
Direct Androgen Receptor Antagonism Enhances Therapeutic PSMA Radioligand Uptake in Prostate Cancer Models
Philipp E Hartrampf, Sebastian E Serfling, Natalie Hasenauer, et al.
Nuklearmedizin. Nuclear Medicine
|
February 25, 2026
Emerging Theranostic Targets in Squamous Cell Carcinoma of the Head and Neck
Sophie C Siegmund, Sebastian E Serfling, Takahiro Higuchi, et al.
Molecular Imaging and Biology
|
January 4, 2024
Evaluating the Patterns of FAPI Uptake in the Shoulder Joint: a Preliminary Study Comparing with FDG Uptake in Oncological Studies
Yohji Matsusaka, Rudolf A Werner, Sebastian E Serfling, et al.
Clinical Nuclear Medicine
|
March 17, 2023
Partial Response Upon Peptide Receptor Radionuclide Therapy in a Highly Proliferative Pancreatic Neuroendocrine Tumor
Alexander Weich, Sebastian E Serfling, Steven P Rowe, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 11, 2022
CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection
Alessandro Lambertini, Philipp E Hartrampf, Takahiro Higuchi, et al.
Seminars in Nuclear Medicine
|
May 26, 2023
Role of Functional SPECT and PET in Renal Emergencies
Takahiro Higuchi, Philipp E Hartrampf, Andreas K Buck, et al.
Annals of Nuclear Medicine
|
October 27, 2023
Comparison of PET/CT-based eligibility according to VISION and TheraP trial criteria in end-stage prostate cancer patients undergoing radioligand therapy
Kerstin Michalski, Aleksander Kosmala, Rudolf A Werner, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 8, 2022
CXCR4-targeted theranostics in oncology
Andreas K Buck, Sebastian E Serfling, Thomas Lindner, et al.
Cancers
|
September 10, 2021
Development of Discordant Hypermetabolic Prostate Cancer Lesions in the Course of [<sup>177</sup>Lu]PSMA Radioligand Therapy and Their Possible Influence on Patient Outcome
Philipp E Hartrampf, Constantin Lapa, Sebastian E Serfling, et al.
Endocrine
|
December 22, 2023
[<sup>18</sup>F]FDG PET/CT can trigger relevant oncological management changes leading to favorable outcome in iodine-negative thyroid cancer patients
Yingjun Zhi, Takahiro Higuchi, Stephan Hackenberg, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 72) with videos related to
Sort By:
Page
of 8
Molecular Imaging and Biology
|
June 21, 2026
Direct Androgen Receptor Antagonism Enhances Therapeutic PSMA Radioligand Uptake in Prostate Cancer Models
Philipp E Hartrampf, Sebastian E Serfling, Natalie Hasenauer, et al.
Nuklearmedizin. Nuclear Medicine
|
February 25, 2026
Emerging Theranostic Targets in Squamous Cell Carcinoma of the Head and Neck
Sophie C Siegmund, Sebastian E Serfling, Takahiro Higuchi, et al.
Molecular Imaging and Biology
|
January 4, 2024
Evaluating the Patterns of FAPI Uptake in the Shoulder Joint: a Preliminary Study Comparing with FDG Uptake in Oncological Studies
Yohji Matsusaka, Rudolf A Werner, Sebastian E Serfling, et al.
Clinical Nuclear Medicine
|
March 17, 2023
Partial Response Upon Peptide Receptor Radionuclide Therapy in a Highly Proliferative Pancreatic Neuroendocrine Tumor
Alexander Weich, Sebastian E Serfling, Steven P Rowe, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 11, 2022
CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection
Alessandro Lambertini, Philipp E Hartrampf, Takahiro Higuchi, et al.
Seminars in Nuclear Medicine
|
May 26, 2023
Role of Functional SPECT and PET in Renal Emergencies
Takahiro Higuchi, Philipp E Hartrampf, Andreas K Buck, et al.
Annals of Nuclear Medicine
|
October 27, 2023
Comparison of PET/CT-based eligibility according to VISION and TheraP trial criteria in end-stage prostate cancer patients undergoing radioligand therapy
Kerstin Michalski, Aleksander Kosmala, Rudolf A Werner, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 8, 2022
CXCR4-targeted theranostics in oncology
Andreas K Buck, Sebastian E Serfling, Thomas Lindner, et al.
Cancers
|
September 10, 2021
Development of Discordant Hypermetabolic Prostate Cancer Lesions in the Course of [<sup>177</sup>Lu]PSMA Radioligand Therapy and Their Possible Influence on Patient Outcome
Philipp E Hartrampf, Constantin Lapa, Sebastian E Serfling, et al.
Endocrine
|
December 22, 2023
[<sup>18</sup>F]FDG PET/CT can trigger relevant oncological management changes leading to favorable outcome in iodine-negative thyroid cancer patients
Yingjun Zhi, Takahiro Higuchi, Stephan Hackenberg, et al.
Page
of 8